Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male
Primary hyperparathyroidism is a very rare complication following radioactive iodine therapy. There is typically a latency period of more than a decade following radiation exposure and, therefore, it is observed almost exclusively in adults. Consequently, pediatricians are not aware of the associati...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2014/163848 |
id |
doaj-22fd82c15d23430e95dd1fe93dc9b380 |
---|---|
record_format |
Article |
spelling |
doaj-22fd82c15d23430e95dd1fe93dc9b3802020-11-24T23:46:43ZengHindawi LimitedCase Reports in Pediatrics2090-68032090-68112014-01-01201410.1155/2014/163848163848Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent MaleDanielle L. Gomez0Dorothy I. Shulman1University of South Florida Diabetes Center, Department of Pediatrics, University of South Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 62, Tampa, FL 33612, USAUniversity of South Florida Diabetes Center, Department of Pediatrics, University of South Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 62, Tampa, FL 33612, USAPrimary hyperparathyroidism is a very rare complication following radioactive iodine therapy. There is typically a latency period of more than a decade following radiation exposure and, therefore, it is observed almost exclusively in adults. Consequently, pediatricians are not aware of the association. We present a case of primary hyperparathyroidism due to a solitary parathyroid adenoma occurring in an adolescent male two years following radioactive iodine treatment for papillary thyroid carcinoma. Periodic screening of serum calcium following ablative doses of radioactive iodine for thyroid cancer may be justified even in adolescents.http://dx.doi.org/10.1155/2014/163848 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Danielle L. Gomez Dorothy I. Shulman |
spellingShingle |
Danielle L. Gomez Dorothy I. Shulman Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male Case Reports in Pediatrics |
author_facet |
Danielle L. Gomez Dorothy I. Shulman |
author_sort |
Danielle L. Gomez |
title |
Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_short |
Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_full |
Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_fullStr |
Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_full_unstemmed |
Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_sort |
hyperparathyroidism two years after radioactive iodine therapy in an adolescent male |
publisher |
Hindawi Limited |
series |
Case Reports in Pediatrics |
issn |
2090-6803 2090-6811 |
publishDate |
2014-01-01 |
description |
Primary hyperparathyroidism is a very rare complication following radioactive iodine therapy. There is typically a latency period of more than a decade following radiation exposure and, therefore, it is observed almost exclusively in adults. Consequently, pediatricians are not aware of the association. We present a case of primary hyperparathyroidism due to a solitary parathyroid adenoma occurring in an adolescent male two years following radioactive iodine treatment for papillary thyroid carcinoma. Periodic screening of serum calcium following ablative doses of radioactive iodine for thyroid cancer may be justified even in adolescents. |
url |
http://dx.doi.org/10.1155/2014/163848 |
work_keys_str_mv |
AT daniellelgomez hyperparathyroidismtwoyearsafterradioactiveiodinetherapyinanadolescentmale AT dorothyishulman hyperparathyroidismtwoyearsafterradioactiveiodinetherapyinanadolescentmale |
_version_ |
1725492656656613376 |